|UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C.  20549

FORM 10-Q



(Mark One)

[ X ]
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934.

For the Period Ended June 30, 2002




.

[    ]
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES
EXCHANGE ACT OF 1934.



Commission File Number:   0 - 16612


CNS, INC.
(Exact name of registrant as specified in its charter)

Delaware
41-1580270
(State or other jurisdiction of
(I.R.S. Employer
incorporation or organization)
Identification No.)


P.O. BOX 39802
Minneapolis, MN  55439
(Address of principal executive offices including zip code)

(952) 229-1500
(Registrant's telephone number, including area code)




Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15 (d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to  file such reports), and (2) has been subject to such filing requirements for the past 90 days.


YES
X
NO



At July 31, 2002, the Company had outstanding 13,514,934 shares of common stock, $.01 par value per share.

1
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|PART I  FINANCIAL INFORMATION
Item 1. Financial Statements

CNS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(unaudited)(in thousands, except per share amounts)
|----------------------------------------------------------------------------------------------------------------------------------------------------------------

|                                                        
|--------------------------------------------------------
|                                                        
|ASSETS                                                  
|Current assets:                                         
|Cash and cash equivalents                               
|Marketable securities                                   
|Accounts receivable, net                                
|Inventories                                             
|Deferred income taxes                                   
|Prepaid expenses and other current assets               
|                                                        
|Total current assets                                    
|Property and equipment, net                             
|Product rights, net                                     
|Deferred income taxes                                   
|                                                        
|                                                        
|                                                        
|                                                        
|                                                        
|LIABILITIES AND STOCKHOLDERS EQUITY                    
|Current liabilities:                                    
|Accounts payable and accrued expenses                   
|                                                        
|Total current liabilities                               
|Stockholders equity:                                   
|Preferred stock  authorized 8,484 shares;              
|none issued or outstanding                              
|Common stock  $.01 par value; authorized 50,000 shares;
|issued 19,295 shares                                    
|Additional paid-in capital                              
|Treasury shares  at cost; 5,754 at June 30, 2002 and   
|5,756 at March 31, 2002                                 
|Retained earnings                                       
|Accumulated other comprehensive income                  
|                                                        
|Total stockholders equity                              
|                                                        
|                                                        
|                                                        

|The accompanying notes are an integral partof the
condensed consolidated financial statements.



2
|---------------------------------------------------------------------------------------------------

|CNS, INC.CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited)(in thousands, except per share amounts)
|------------------------------------------------------------------------------------------------------------

|                                     
|-------------------------------------
|                                     
|2002                                 
|                                     
|Net sales                            
|Cost of goods sold                   
|                                     
|Gross profit                         
|                                     
|Operating expenses:                  
|Advertising and promotion            
|Selling, general and administrative  
|Special charges                      
|                                     
|Total operating expenses             
|                                     
|Operating income (loss)              
|Interest income                      
|                                     
|Income (loss) before income taxes    
|Income tax expense                   
|                                     
|Net income (loss)                    
|                                     
|                                     
|Basic net income (loss) per share    
|                                     
|Diluted net income (loss) per share  
|                                     
|                                     
|Weighted average number of common    
|shares outstanding                   
|                                     
|Weighted average number of common and
|assumed conversion shares outstanding
|                                     

|The accompanying notes are an integral part
of the condensed consolidated financial statements.



3
|----------------------------------------------------------------------------------------------------

|CNS, INC.CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(unaudited)(in thousands)
|----------------------------------------------------------------------------------

|                                                      
|------------------------------------------------------
|                                                      
|2002                                                  
|                                                      
|Operating activities:                                 
|Net income (loss)                                     
|Adjustments to reconcile net income (loss) to net cash
|from operating activities:                            
|Depreciation and amortization                         
|Deferred income taxes                                 
|Changes in operating assets and liabilities:          
|Accounts receivable                                   
|Inventories                                           
|Prepaid expenses and other current assets             
|Accounts payable and accrued expenses                 
|                                                      
|Net cash from operating activities                    
|                                                      
|Investing activities:                                 
|Net change in marketable securities                   
|Payments for purchases of property and equipment      
|Payments for product rights                           
|                                                      
|Net cash from investing activities                    
|                                                      
|Financing activities:                                 
|Proceeds from issuance of common stock                
|under stock plans                                     
|Purchase of treasury shares                           
|                                                      
|Net cash from financing activities                    
|                                                      
|Net change in cash and cash equivalents               
|Cash and cash equivalents:                            
|Beginning of period                                   
|                                                      
|End of period                                         
|                                                      

|The accompanying notes are an integral partof the
condensed consolidated financial statements.



4
|---------------------------------------------------------------------------------------------------

|NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

The accompanying condensed consolidated financial statements
as of June 30, 2002 and 2001 and March 31, 2002 are unaudited but, in the
opinion of management, include all adjustments (consisting only of normal,
recurring accruals) necessary for a fair presentation of results for the periods
presented.

In 2002 the Company changed its fiscal year-end from December
31 to March 31. The change in its fiscal year-end aligns the Companys
financial reporting period with its business and customer-planning cycle. The
Company believes this change provides a clearer picture of the Companys
financial results by including an entire cough/cold season within the same
fiscal year.

Note 1  Accounting Principles
The accounting principles followed in
the preparation of the financial information contained herein are the same as those
described in the Companys Annual Report on Form 10-K for the year ended December
31, 2001 with the exception of the following new pronouncements being adopted during the
quarter ended March 31, 2002:
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | The
Company implemented Emerging Issues Task Force bulletins Number 00-14 Accounting
for Certain Sales Incentives and Number 00-25 Vendor Income Statement
Characterization of Consideration Paid to a Reseller. These new accounting
standards had no impact on the Companys net income; however, they did require
reclassification of certain promotional costs such as sales incentives, promotional
funds, and consumer coupon redemption that were previously reported as a component of
advertising and promotion expense as a reduction of net revenue. This resulted in revenue
reductions of $800,000 in the quarter ended June 2002 and $1.1 million in the quarter
ended June 2001, with corresponding reductions in advertising and promotion expense
during those periods.
| | --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | The
Company implemented Statement of Financial Accounting Standards
(SFAS) No. 144, Accounting for the Impairment or Disposal of
Long-Lived Assets. This statement supercedes SFAS No. 121,
Accounting for the Impairment of Long-Lived Assets and for Long-Lived
Assets to Be Disposed Of. There was no material impact on the
Companys consolidated financial position or results of operations as the
result of implementing this standard.
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Refer to the Annual Report on Form 10-K for detailed
information on accounting policies.

Note 2  Comprehensive Income (Loss)A reconciliation of total
comprehensive income (loss) is as follows (in thousands):



5
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|
|

|                                              
|----------------------------------------------
|                                              
|2002                                          
|                                              
|Net income (loss)                             
|Change in unrealized gain (loss) on marketable
|securities, net of income tax                 
|                                              
|Total comprehensive income (loss)             
|                                              

|Note 3  Earnings Per ShareA reconciliation of weighted average
common and assumed conversion shares outstanding is as follows (in thousands):
|----------------------------------------------------------------------------------------------------------------------------------------------

|                                   
|-----------------------------------
|                                   
|2002                               
|                                   
|Average common shares outstanding  
|Assumed conversion of stock options
|                                   
|Average common and assumed         
|conversion shares                  
|                                   

|Note 4  Income TaxesAs part of the process of preparing financial
statements, the Company is required to estimate income taxes, both state and federal.
This process involves management estimating the actual current tax exposure together with
assessing temporary differences resulting from different treatment for tax and accounting
purposes. These differences result in deferred tax assets and liabilities, which are
included within the consolidated balance sheet. Management must then assess the
likelihood that deferred tax assets will be utilized to offset future taxable income
during the periods in which these temporary differences are deductible. Management
believes that as of June 30, 2002, based on the level of historical taxable income and
projections of future taxable income for the periods in which the deferred tax assets are
deductible, that it is more likely than not the Company will realize the benefits of
these deductible differences.


6
|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Item 2.    Management's Discussion and Analysis of Financial Condition and
Results of Operations

This Report on Form 10-Q should be read in conjunction with the Companys
Annual Report on Form 10-K for the period ended December 31, 2001.

In 2002 the Company changed its fiscal year-end from December
31 to March 31. The change in its fiscal year-end aligns the Companys
financial reporting period with its business and customer-planning cycle. The
Company believes this change provides a clearer picture of the Companys
financial results by including an entire cough/cold season within the same
fiscal year.

The Companys revenues are derived primarily from the
manufacture and sale of the Breathe Right® nasal strip, which is a
nonprescription, disposable device designed to improve nasal breathing and
temporarily relieve nasal congestion, and to reduce or eliminate snoring and
breathing difficulties due to a deviated nasal septum. The Company began
marketing FiberChoice® chewable tablets, an innovative bulk fiber supplement
in the June quarter of 2000.

The Company has experienced in the past, and expects to
experience in the future, quarterly fluctuations in both domestic and
international sales and earnings. These fluctuations are due in part to
advertising levels and seasonality of sales, as described below, as well as
increases and decreases in purchases by distributors in anticipation of future
demand by consumers.

Results of Operations

Net sales for the June 2002 quarter were $14.5 million versus
$14.4 million in the June 2001 quarter. Net sales, before the effect of
accounting reclassifications described in Note 1, for the June 2002 quarter were
$15.3 million compared to $15.5 million in the 2001 period.

Domestic sales for the June quarter of 2002 were $12.7 million
compared to $11.4 million for the same quarter of 2001. Sales for the 2002 June
quarter were higher due to increased retailer purchases of Breathe Right nasal
strips in line with a return to growing consumer purchases.

International sales were $1.8 million for the June quarter of
2002 compared to $2.9 million for the same quarter of 2001. Lower sales for the
2002 June quarter are primarily due to a Japanese distributor having excess
inventory at the end of last years cold and allergy season, resulting in
lower purchases during the current quarter.

Gross profit was $9.2 million for the June quarter of 2002
compared to $8.8 million for the same quarter of 2001. Gross profit as a
percentage of net sales increased to 63.4% for the June quarter of 2002 compared
to 61.3% for the same quarter of 2001. The higher gross profit percentage in
2002 resulted primarily from reduced operating costs and lower deductions from
sales for promotional expenditures.

Advertising and promotion expenses were $4.1 million for the
June quarter of 2002 compared to $7.5 million for the same quarter of 2001.
Expenditures for the Breathe Right brand declined by $1.9 million, due to
dropping the allergy-focused advertising that was tested during the 2001 June quarter.
Advertising and


7
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|promotion expense for the FiberChoice brand was down by $1.7
million, as spending levels were reduced in the year following the product launch.

Selling, general and administrative expenses were $2.8 million
for the June quarter of 2002 compared to $3.5 million for the same quarter of
2001. This decrease was primarily the result of the June 2001 corporate
restructuring that included a workforce reduction and that has enabled the
Company to streamline its resources to focus on building the core businesses.
Product development costs were less than expected due to a delay in some product
development expenditures. The Company incurred a special charge of $1.1 million
during the June 2001 quarter relating to the restructuring.

Operating income for the June quarter of 2002 was $2.3 million compared
to a loss of $3.3 million for the same quarter of 2001.

Investment income was $200,000 for the June quarter of 2002
compared to $300,000 for the same quarter of 2001. The decrease was primarily
the result of lower market interest rates.

Net income for the June quarter of 2002 was $1.6 million
compared to a net loss of $3.0 million for the same quarter of 2001. There was
no income tax benefit recognized for the June quarter of 2001.

Seasonality

The Company believes that a portion of Breathe Right nasal
strip use is for the temporary relief of nasal congestion and congestion-related
snoring. Sales of nasal congestion remedies are higher during the fall and
winter seasons because of increased use during the cold and allergy seasons.

Liquidity and Capital Resources

At June 30, 2002, the Company had cash, cash equivalents and marketable
securities of $29.6 million and working capital of $40.1 million.

Company operations provided cash of $5.1 million for the June
quarter of 2002 compared with a use of cash of $400,000 for the same quarter of
2001. Net income, that included non cash tax expense of $1.0 million, and a
decrease in accounts receivable offset partially by payment of operating
liabilities provided the positive impact on cash for the June 2002 quarter.

The Company had net purchases of $5.1 million of marketable securities
in the June quarter of 2002 compared to sales of $700,000 for the same quarter of 2001.

The Company repurchased 89,600 shares of common stock for $500,000 in
the June quarter of 2002. This leaves 900,100 shares that can be repurchased out of the
board of directorsmost recent authorization. The shares of common stock are
available for use by the Company to meet its obligations under its employee stock
ownership plan and\ stock option plans, and for possible future acquisitions.


8
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|The Company believes that its existing funds and funds generated from
operations will be sufficient to support its planned operations for the foreseeable
future.

Accounting Policies and Recent Accounting Pronouncements

In preparing the consolidated financial statements in conformity
with accounting principles generally accepted in the United States, management
must make decisions which impact the reported amounts and related disclosures.
Such decisions include the selection of the appropriate principles to be applied
and the assumptions on which to base accounting estimates. In reaching such
decisions, management applies judgement based on its understanding and analysis
of the relevant circumstances. Note 1 to the condensed consolidated financial
statements and the Companys Annual Report on Form 10-K for the year ended
December 31, 2001 provide important information about the significant accounting
policies followed in the preparation of the Companys financial statements
and accounting pronouncements applicable to the Company.

Forward-Looking Statements

Certain statements contained in this Report on Form 10-Q and other
written and oral statements made from time to time by the Company do not relate strictly
to historical or current facts but provide current expectations or forecasts of future
events. As such, they are considered forward-looking statements under the
Private Securities Litigation Reform Act of 1995 and are subject to certain risks and
uncertainties that could cause actual results to differ materially from those presently
anticipated or projected. Such forward-looking statements can be identified by the use of
terminology such as may, will, expect, plan,
intend, anticipate, estimate, or
continue or similar words or expressions. It is not possible to foresee or
identify all factors affecting the Companys forward-looking statements and
investors therefore should not consider any list of factors to be an exhaustive statement
of all risks, uncertainties or potentially inaccurate assumptions. Factors that could
cause actual results to differ from the results discussed in the forward-looking
statements include, but are not limited to, the following factors: (i) the Companys
revenue and profitability is reliant on sales of Breathe Right nasal strips; (ii) the
Company currently has a seasonal pattern of sales that is typically higher in the March
and December quarters of each year due to increased nasal strip usage during the
cough/cold season and its revenues and earnings may be impacted by the relative severity
of such season; (iii) the Companys success and future growth will depend
significantly on its ability to effectively market Breathe Right nasal strips and upon
its ability to develop and achieve markets for additional products; (iv) the Companys
competitive position will, to some extent, be dependent on the enforceability and
comprehensiveness of the patents on its Breathe Right nasal strip technology which have
been, and in the future may be, the subject of litigation and could be narrowed as a
result of the outcome of the reexamination of one such patent by the United States Patent
and Trademark Office; (v) the Company has faced and will continue to face challenges in
successfully developing and introducing new products; (vi) the Company operates in
competitive markets where recent and potential entrants into the nasal dilator segment
pose competitive challenges; (vii) the Company is dependent upon contract manufacturers
for the production of substantially all of its products; and (viii) the Company


9
|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|currently  purchases most of its major components for its nasal strip
products from different contract manufacturers that obtain the raw materials from a
single supplier.

Item 3.    Quantitative and Qualitative Disclosures about Market Risk

The Companys market risk exposure is primarily interest
rate risk related to its cash, cash equivalents and investments in marketable
securities. The Companys risk to interest rate fluctuations has not
materially changed since December 31, 2001. See Item 7A of the Companys
Annual Report on Form 10-K for the year ended December 31, 2001.
10
|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|PART II  OTHER INFORMATION
|---------------------------

|Item 1. | Legal Proceedings
|------- | -----------------

| | Not Applicable
| | --------------

|Item 2. | Changes
in Securities
|------- | ---------------------

| | Not Applicable
| | --------------

|Item 3. | Defaults
Upon Senior Securities
|------- | -------------------------------

| | Not Applicable
| | --------------

|Item 4. | Submission
of Matters to a Vote of Security Holders
|------- | ---------------------------------------------------

| | On May 15, 2002, CNS, Inc. held its Annual Meeting of Stockholders. Of the 13,530,065 shares
of Common Stock eligible to vote, 12,781,223 were represented in person or by proxy at
the meeting and shares were voted on the following matters:
| | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | 1. The votes cast for the eight (8) directors to serve until the next annual meeting of
shareholders were:
| | ----------------------------------------------------------------------------------------------------------

|Name                   |  | Votes for |  | Votes Withheld | 
|---------------------- |  | --------- |  | -------------- | 
|Daniel E. Cohen        |  |           |  | 12,641,265     | 
|Patrick Delaney        |  |           |  | 11,840,770     | 
|R. Hunt Greene         |  |           |  | 11,887,600     | 
|Andrew J. Greenshields |  |           |  | 11,891,870     | 
|H. Robert Hawthorne    |  |           |  | 12,669,210     | 
|Marti Morfitt          |  |           |  | 12,636,607     | 
|Richard A. Peddie      |  |           |  | 12,668,130     | 
|Richard W. Perkins     |  |           |  | 11,869,628     | 

| | 2. The votes cast to ratify and approve the appointment of KPMG LLP as independent auditors
for the fiscal year ending March 31, 2003 were:
| | -------------------------------------------------------------------------------------------------------------------------------------------

|
|
|

|Item 5. | Other
Information
|------- | -----------------

| | Because the Companys fiscal year has recently changed to a fiscal year ending March 31, the
Company plans to hold its 2003 Annual Meeting of Stockholders on or about August 27,
2003. The Company anticipates mailing its proxy materials in connection with the 2003
Annual Meeting of Stockholders on or about July 14, 2003.
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|11
|--

| | For a stockholder proposal to be considered for inclusion in the Companys Proxy
Statement for the 2003 Annual Meeting of Stockholders, the proposal must be in writing
and received by the Secretary of the Company at its corporate offices no later than March
17, 2003. The Board of Directors of the Company will consider shareholder proposals and
nominations submitted in connection with the 2003 Annual Meeting of Stockholders to be
timely for purposes of the procedure established in the Companys Bylaws if received
between May 15, 2003 and May 30, 2003.
| | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

| | In addition to meeting the deadlines noted above and complying with applicable
rules of the Securities Exchange Act of 1934, stockholder proposals must also
meet the requirements described in the Companys Bylaws and summarized in
the section entitled Stockholder Proposals in the Companys
definitive proxy statement for the 2002 Annual Meeting of Stockholders held on
May 15, 2002.
| | -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

|Item 6. | Exhibits
and Reports on Form 8-K
|------- | --------------------------------

| | (a) | The
following exhibits are filed as part of this Report:
| | --- | --------------------------------------------------------

| |  | 99.1 | Certification
pursuant to 18 U.S.C. Section 1350.
| |  | ---- | -------------------------------------------------

| | (b) | Reports
on Form 8-K
| | --- | -------------------

| |  | None | 
| |  | ---- | 

|12
|--

|SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.




CNS, Inc.

Registrant





Date:
August 9, 2002

By:
/s/  Marti Morfitt

Marti Morfitt
President & Chief Executive Officer





Date:
August 9, 2002

By:
/s/  David J. Byrd

David J. Byrd
Vice President of Finance, Chief
Financial Officer and Treasurer
13
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------